Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI)
Open Access
Abstract
Objective To develop and validate the evidence-based and consensus-based Behçet’s Syndrome Overall Damage Index (BODI). Methods Starting from 120 literature-retrieved preliminary items, the BODI underwent multiple Delphi rounds with an international multidisciplinary panel consisting of rheumatologists, internists, ophthalmologists, neurologists, and patient delegates until consensus was reached on the final content. The BODI was validated in a cross-sectional multicentre cohort of 228 patients with Behçet’s syndrome (BS) through the study of (a) correlation between BODI and Vasculitis Damage Index (VDI) and (b) correlation between BODI and disease activity measures (ie, Behçet’s Disease Current Activity Form (BDCAF), Physician Global Assessment (PGA), Patient Global Assessment (PtGA)), c) content and face validity and (d) feasibility. Results The final BODI consists of 4 overarching principles and 46 unweighted-items grouped into 9 organ domains. It showed good to excellent reliability, with a mean Cohen’s k of 0.84 (95% CI 0.78 to 0.90) and a mean intra-class correlation coefficient of 0.88 (95% CI 0.80 to 0.95). Overall, 128 (56.1%) patients had a BODI score ≥1, with a median score of 1.0 (range 0–14). The BODI significantly correlated with the VDI (r=0.693, pConclusions Pending further validation, the BODI may be used to assess organ damage in patients with BS in the context of observational and controlled trials.Keywords
This publication has 25 references indexed in Scilit:
- 2018 update of the EULAR recommendations for the management of Behçet's syndromeAnnals of the Rheumatic Diseases, 2018
- Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trialsAnnals of the Rheumatic Diseases, 2015
- Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0Journal of Clinical Epidemiology, 2014
- Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct ValidityThe Journal of Rheumatology, 2014
- Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic ReviewThe Journal of Rheumatology, 2014
- The origin of Behçet's disease geoepidemiology: possible role of a dual microbial-driven genetic selection.2014
- Impaired Health-related Quality of Life in Patients Treated for Wegener’s GranulomatosisThe Journal of Rheumatology, 2010
- Behcet’s disease: from east to westClinical Rheumatology, 2010
- Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitidesArthritis & Rheumatism, 1997
- The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosusArthritis & Rheumatism, 1996